mrd negativity in npm1-mutated aml: the influence of co-occurring mutations and flag-ida induction
Published 8 months ago • 128 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
3:05
mrd negativity assessed by flow cytometry associated with improved outcomes in npm1-mutated aml
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy
-
1:38
value of mrd in patients with npm1-mutated aml
-
3:55
ziftomenib: a menin inhibitor for r/r npm1-mutated aml
-
2:25
master final analysis: quadruplet induction therapy, asct & mrd-adapted treatment cessation in ndmm
-
1:05:07
euretina case club with prof adnan tufail (nov 10th, 2021)
-
3:18
midiagnostics' complete blood count (cbc) - blood analysis for diagnosis and monitoring
-
1:59:56
mmyprespt2hd2024
-
4:22
the role of mrd in aml
-
1:11
distinkt trial analysis: efficacy and safety of imc-001 for r/r enktl
-
3:27
the role of mrd in aml regulatory decision making
-
0:44
the clinical meaning of mrd below the threshold of mcr in aml
-
1:04
real-world findings of mrd by mfc in aml
-
2:23
the role of mrd monitoring using mfc for aml: a real-world study
-
1:19
al amyloidosis: mrd negativity
-
1:39
an insight into mrd monitoring and mrd-driven treatment in aml
-
1:32
methods to evaluate mrd in aml
-
1:49
bringing precision medicine and mrd into clinical strategies
-
1:40
updates on the use of molecular monitoring to detect mrd in aml
-
2:24
menin inhibitors are on the horizon for npm1 mutated aml | eytan stein | ash 2021 #aml
-
3:31
post-induction undetectable mrd ameliorates the high risk determined by fish among ndmm
-
1:30
the clinical application of mrd testing in aml